glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple- Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Ratiometrically designed nanoprodrug for triple negative breast cancer treatment Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



